Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02587663 · ClinicalTrials.gov registry record · NA
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT02587663: Completed NA study, sponsored by University of Southern California.
NCT02587663 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02587663, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
This clinical trial studies mammography and targeted ultrasound with or without whole-breast ultrasound or contrast-enhanced magnetic resonance imaging (MRI) in finding out the extent of disease before surgery in patients with newly diagnosed breast cancer. New diagnostic imaging procedures, such as whole-breast ultrasound or contrast-enhanced MRI, may help find out how far breast cancer has spread. It is not yet known whether mammography and targeted ultrasound are more effective with or without whole-breast ultrasound or contrast-enhanced MRI in finding out how far breast cancer has spread.
Primary Outcome
Every attempt will be made to identify a transformation for the difference in the lengths of the largest diameters. If none are found, then the data will be summarized with histograms, medians, quartiles, and ranges. If a transformation is found, means, standard deviations, and 95% confidence intervals will be reported instead of the median and quartiles. Differences between three imaging methods will be compared using a paired t-test (or paired rank sum test).
Interventions
- PROCEDURE Therapeutic Conventional Surgery
- PROCEDURE Mammography
- PROCEDURE Contrast-enhanced Magnetic Resonance Imaging
- PROCEDURE Ultrasonography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2005-11-20 |
| Est. Completion | 2012-11-20 |
| Phase | NA |
What the finished NCT02587663 record still lists
NCT02587663 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 4 interventions - of which Therapeutic Conventional Surgery is the first listed.
NCT02587663 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02587663 about?
NCT02587663 is a clinical study titled "Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI". This clinical trial studies mammography and targeted ultrasound with or without whole-breast ultrasound or contrast-enhanced magnetic resonance imaging (MRI) in finding out the extent of disease before surgery in patients with newly diagnosed breast cancer. New diagnostic imaging procedures, such as...
What is the current status of trial NCT02587663?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2005-11-20. Estimated completion is 2012-11-20.
What interventions are being tested in trial NCT02587663?
The interventions under investigation include: Therapeutic Conventional Surgery (PROCEDURE), Mammography (PROCEDURE), Contrast-enhanced Magnetic Resonance Imaging (PROCEDURE), Ultrasonography (PROCEDURE).
Who is sponsoring clinical trial NCT02587663?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02587663's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI